Home Healthcare Industry News Update

The report "Home Healthcare Market by Product (Therapeutic, Testing, Screening, Monitoring, Mobility Care), Service (Nursing, Infusion Therapy, Rehabilitation, Palliative Care), Indication (Cancer, Diabetes, CVD, Respiratory, Wound Care) - Global Forecast to 2030", is valued at an estimated USD 309.9 billion in 2025. The size is projected to reach USD 473.8 billion by 2030, at a CAGR of 8.9%.

Browse 295 market data Tables and 52 Figures spread through 349 Pages and in-depth TOC on "Home Healthcare Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/home-healthcare-equipment-market-696.html

This growth, at a projected compound annual growth rate (CAGR) of 8.9% during the forecast period, reflects a strong and sustained demand for home healthcare products worldwide. The rapid expansion of the home healthcare market is primarily driven by the growing elderly population, who often require continuous medical attention and long-term management of chronic conditions such as diabetes, heart disease, and arthritis. As the demand for healthcare rises, so do the associated costs, prompting patients and healthcare providers to explore more affordable alternatives to hospital-based care.

Home healthcare offers a cost-effective solution, reducing the financial burden while maintaining the quality of care. Moreover, breakthroughs in technology, such as telehealth platforms, wearable health monitors, and smart medical devices, have significantly improved the ability to provide timely, efficient, and personalized care within the home setting. These developments are transforming the healthcare landscape, encouraging a global shift toward patient-centered, home-based care models that prioritize comfort, convenience, and improved health outcomes.

The therapeutic products segment is projected to register the largest share of the home healthcare market, by product segment, in 2024.

The home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. In 2024, therapeutic products held the largest share. This dominance is largely attributed to the increasing prevalence of chronic diseases such as diabetes, cancer, and kidney failure, which require ongoing treatment and management. As more patients seek convenient, long-term care solutions, there is a growing reliance on therapeutic equipment that can be used safely and effectively at home. These products, including infusion pumps, dialysis machines, and respiratory therapy devices, play a crucial role in improving patient outcomes while reducing hospital visits. The rising demand for personalized and continuous care has solidified the position of therapeutic items as a key driver in the home healthcare market.

The infusion therapy services segment secured the highest growth rate during the study period.

The home healthcare market, based on service, is divided into skilled nursing services, rehabilitation therapy services, hospice & palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. In 2024, skilled nursing services accounted for the largest share of the home healthcare market. This leading position is primarily due to the increasing demand for professional medical care at home, particularly among the elderly population. As people age, they are more likely to develop complex and chronic health conditions requiring continuous monitoring, medication administration, wound care, and post-surgical support, typically delivered by licensed nurses. The growing aging demographic, coupled with a strong preference for receiving care in familiar, comfortable environments, is fueling the expansion of skilled nursing services. Additionally, advancements in home medical equipment and support from insurance providers have made home-based nursing care more accessible and efficient, further driving market growth.

The Asia Pacific market is expected to witness the highest growth during the forecast period.

The home healthcare market is segmented into six major regional segments, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. Among these, the Asia Pacific region is expected to witness the fastest growth, with a projected compound annual growth rate (CAGR) of 10.1% during the forecast period. This rapid expansion is driven by several key factors, including the presence of emerging economies such as China, India, and Japan, which are experiencing a surge in healthcare demand.

This rapid growth is primarily driven by increasing disposable incomes, which are enabling more individuals to afford quality healthcare services, including home-based care. Additionally, governments across countries such as China, India, Japan, and South Korea are launching initiatives to promote home healthcare, aiming to reduce pressure on overburdened hospitals and improve healthcare access in urban and rural areas. These efforts include policy reforms, public awareness campaigns, and investments in digital health infrastructure. The combination of improved economic conditions and supportive government measures creates a favorable environment for expanding home healthcare services across the Asia Pacific region.

Key Players

Prominent players in the home healthcare market include Fresenius Medical Care AG (Germany), Abbott (US), Linde plc (Ireland), F. Hoffmann-La Roche, Ltd (Switzerland), ResMed (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), A&D HOLON Holdings Company, Limited, Convatec Group PLC (UK), Amedisys (US), OMRON Healthcare Co., Ltd. (Japan), Invacare Corporation (US), BAYADA Home Health Care (US), Drive DeVilbiss Healthcare (UK), Sunrise Medical (Germany),  Roma Medical (UK), Caremax Rehabilitation Equipment Co., Ltd. (China), Vitalograph (UK), Advita Pflegedienst (Germany), RENAFAN Group (Germany), CONTEC MEDICAL SYSTEMS CO., LTD. (China), B. Braun SE (Germany), Baxter (US), Medline Industries (US), and Advin Health Care (India), amongst others.

Don’t miss out on business opportunities in Home Healthcare Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/